These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16022181)

  • 21. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
    Gannon RL; Millan MJ
    Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
    Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
    Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.
    Krystal JH; Mathew SJ; D'Souza DC; Garakani A; Gunduz-Bruce H; Charney DS
    CNS Drugs; 2010 Aug; 24(8):669-93. PubMed ID: 20658799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455.
    East SP; Gerlach K
    Expert Opin Ther Pat; 2010 Mar; 20(3):441-5. PubMed ID: 20180624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.
    Tharmalingam S; Burns AR; Roy PJ; Hampson DR
    Neuropharmacology; 2012 Sep; 63(4):667-74. PubMed ID: 22652059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases.
    Prabhu SV; Singh SK
    Curr Top Med Chem; 2019; 19(29):2687-2707. PubMed ID: 31702505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presynaptic modulation by metabotropic glutamate receptors of excitatory and inhibitory synaptic inputs to hypothalamic magnocellular neurons.
    Schrader LA; Tasker JG
    J Neurophysiol; 1997 Feb; 77(2):527-36. PubMed ID: 9065826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells.
    Neugebauer V; Chen PS; Willis WD
    J Neurophysiol; 1999 Jul; 82(1):272-82. PubMed ID: 10400956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of endogenous ligand specificity divergence among metabotropic glutamate receptors.
    Kang HJ; Wilkins AD; Lichtarge O; Wensel TG
    J Biol Chem; 2015 Jan; 290(5):2870-8. PubMed ID: 25519912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
    Litim N; Morissette M; Di Paolo T
    Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabotropic glutamate receptor agonists alter neuronal excitability and Ca2+ levels via the phospholipase C transduction pathway in cultured Purkinje neurons.
    Netzeband JG; Parsons KL; Sweeney DD; Gruol DL
    J Neurophysiol; 1997 Jul; 78(1):63-75. PubMed ID: 9242261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
    Le Vasseur M; Ran I; Lacaille JC
    Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs.
    Flor PJ; Acher FC
    Biochem Pharmacol; 2012 Aug; 84(4):414-24. PubMed ID: 22554564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
    Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
    Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.